Clinical Trials Browser

Phase 2 × selinexor × Breast × Clear all

NCT02402764 2020-09-11

Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC)

Phase 2 Completed

10 enrolled 7 charts

Breast Neoplasms, Triple Negative Breast Neoplasms